Search

Your search keyword '"Robinson, Philip A."' showing total 3,159 results

Search Constraints

Start Over You searched for: Author "Robinson, Philip A." Remove constraint Author: "Robinson, Philip A."
3,159 results on '"Robinson, Philip A."'

Search Results

1. AI in radiological imaging of soft-tissue and bone tumours: a systematic review evaluating against CLAIM and FUTURE-AI guidelines

2. Prolonged persistence of mutagenic DNA lesions in somatic cells

3. Soft tissue tumor imaging in adults: whole-body staging in sarcoma, non-malignant entities requiring special algorithms, pitfalls and special imaging aspects. Guidelines 2024 from the European Society of Musculoskeletal Radiology (ESSR)

6. Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology–Guidelines 2024: imaging immediately after neoadjuvant therapy in soft tissue sarcoma, soft tissue tumor surveillance, and the role of interventional radiology

7. A genome-wide association analysis reveals new pathogenic pathways in gout

9. Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

10. Decolonization in Nursing Homes to Prevent Infection and Hospitalization

11. Assessing past versus present severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection: A survey of criteria for discontinuing precautions in asymptomatic patients testing positive on admission.

12. Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New Zealand.

13. Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19.

14. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

15. Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status.

16. Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial

17. The dekadas of national art : nationality in Soviet music, 1936-1960

18. Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in gout

19. SoundSpaces 2.0: A Simulation Platform for Visual-Acoustic Learning

20. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry

21. Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry

22. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

23. The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19

24. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

25. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

26. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

27. Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case–control analysis from the UK Biobank

28. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

30. Somatic mutagenesis in humans with deficient DNA repair

31. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations

32. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

33. Rapid Adoption of Telemedicine in Rheumatology Care During the COVID‐19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees

34. The impact of COVID-19 on rheumatology training—results from the COVID-19 Global Rheumatology Alliance trainee survey

35. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

37. Audio-Visual Floorplan Reconstruction

38. 41. Assessing Past vs Present COVID-19 Infection: A Survey of Criteria for Discontinuing Precautions in Asymptomatic Patients

39. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

40. 5. The PROTECT Trial: A Cluster Randomized Clinical Trial of Universal Decolonization with Chlorhexidine and Nasal Povidone Iodine Versus Standard of Care for Prevention of Infections and Hospital Readmissions among Nursing Home Residents

41. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases

42. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

43. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

44. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

46. Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry

47. Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance

48. The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice

50. SoundSpaces: Audio-Visual Navigation in 3D Environments

Catalog

Books, media, physical & digital resources